SBIR-STTR Award

Model of ocular irritancy
Award last edited on: 9/18/2002

Sponsored Program
SBIR
Awarding Agency
NIH : NEI
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Robert P Tuckett

Company Information

Neuroscience Research (AKA: Topical Testing Inc)

2381 Sheridan Road
Salt Lake City, UT 84108
   N/A
   N/A
   N/A
Location: Single
Congr. District: 02
County: Salt Lake

Phase I

Contract Number: 1R43EY009483-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1991
Phase I Amount
$50,000
We will use the anterior eye (cornea and conjunctiva) and its sensory innervation as an assay of irritancy and toxic effects. The anterior eye has unique characteristics: extensive use in toxicology, permeability, relative ease of observation, and importance to the input of visual information. In addition, the eye is unique in that receptors innervating the cornea differ from those innervating conjunctiva, and hence comparisons of these populations will likely be useful to assay for deficits in performance of difference types of sensory neurons. The personnel of Topical Testing have expertise in recording from corneal sensory neurons in vivo, in growing (and recording from) neural tissue in vitro, and in the design and fabrication of specialized equipment used in such studies. This Phase I feasibility study will investigate the adaptation of a new technology, which may allow monitoring of activity on a number of neurons simultaneously, and hence may improve the commercial productivity of Topical Testing's methods for estimating the ocular irritancy potential of chemical substances.Awardee's statement of the potential commercial applications of the research:The model system is essentially an "artificial eye" preparation which can be used for a variety of toxicological assays and may eventually substitute for some in vitro assays as required by the FDA for standard drug testing. Hence, it has the potential of wide commercial application.National Eye Institute (NEI)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----